Your browser doesn't support javascript.
loading
Systemic Inflammatory Biomarkers Predict Survival of Patients Treated With Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
Wang, Zhaojuan; Qin, Yujie; Chai, Xuxia; Lu, Lina; Xue, Ping; Lu, Runrun; Miao, Chengrui; Ma, Haimei; Hu, Xiaoyi; Yao, Jiaxi.
Afiliação
  • Wang Z; Department of Pharmacy, Hexi University Affiliated Zhangye People's Hospital, Zhangye, China.
  • Qin Y; Department of Endoscopy Center, Hexi University Affiliated Zhangye People's Hospital, Zhangye, China.
  • Chai X; Department of Laboratory, Hexi University Affiliated Zhangye People's Hospital, Zhangye, China.
  • Lu L; Hexi University School of Medicine, Zhangye, China.
  • Xue P; Hexi University School of Medicine, Zhangye, China.
  • Lu R; Hexi University School of Medicine, Zhangye, China.
  • Miao C; Hexi University School of Medicine, Zhangye, China.
  • Ma H; Hexi University School of Medicine, Zhangye, China.
  • Hu X; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yao J; Department of Urology, Hexi University Affiliated Zhangye People's Hospital, Zhangye, China.
Cancer Control ; 30: 10732748231197511, 2023.
Article em En | MEDLINE | ID: mdl-37673428

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Control Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Control Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China